Skip to main content
Clinical Trials/NL-OMON26201
NL-OMON26201
Completed
Not Applicable

The identification of the optimal treatment strategy for complex appendicitis in the pediatric population; CAPP study

Amsterdam UMC0 sites1,308 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
<p>Acute complex appendicitis</p>
Sponsor
Amsterdam UMC
Enrollment
1308
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • Eligible for inclusion are all children \<18 years old that need to undergo treatment for the suspicion of complex appendicitis. Suspicion of complex appendicitis is based upon the following predefined criteria: \- 4 or more points on our scoring system developed to predict complex appendicitis. This scoring system consists of five variables (clinical, biochemical and radiological, each awarded points). In case the total score is 4 or more points, the patient is likely to have complex appendicitis. Variables included in the scoring system are: \- Diffuse abdominal guarding (3 points) \- CRP level more than 38 mg/L (2 points) \- Signs on ultrasound / imaging indicative for complex appendicitis (2 points) \- More than one day abdominal pain (2 points) \- Temperature more than 37\.5 degrees Celsius (1 point) Or \- High index of suspicion of complex appendicitis by the treating physician. If this is the case, the treating physician will make pre\-treatment note upon what clinical, biochemical or radiological variable the high index of suspicion is based. Classification into the two subgroups of complex appendicitis will be based upon clinical and radiological features. If signs suggestive of perforated appendicitis AND intra\-abdominal abscesses or enlarged mass formation are present, patients will be categorized as subgroup 2\. If no abscess or enlarged mass is present on clinical exam and/or additional imaging, patients will be categorized as subgroup 1\.

Exclusion Criteria

  • 1\. Adult patients (\=18 years old) 2\. Children with a suspicion of simple appendicitis (based upon the previous mentioned scoring system and radiological features)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
OPTIMISE: A study investigating if analysis of cancer DNA in blood can be used to guide adjuvant treatment in patients with advanced colorectal cancerMedDRA version: 21.0Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-004524-41-DKAarhus University Hospital/Karen-Lise Garm Spindler350
Active, not recruiting
Phase 1
OPTIMISEColorectal cancer with metastasisTherapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2023-509814-12-00Region Midtjylland350
Not yet recruiting
Phase 1
The efficacy and safety of chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: a multi-centre, randomized, double-blind, placebo-controlled trialDiabetic Lower Extremity Artery Disease
ITMCTR1900002645Hospital of Chengdu University of Traditional Chinese Medicine
Recruiting
Phase 1
Determination of effective therapeutic regimen via Levamisole in controlling the idiopathic nephrotic syndrome relapse among childre
IRCT20180519039715N3Kermanshah University of Medical Sciences188
Completed
Not Applicable
Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study
JPRN-C000000106The J-RHYTHM Investigators2,600